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Abstract
Dengue virus is responsible for the highest rates of disease and mortality among the members of the Flavivirus genus.
Dengue epidemics are still occurring around the world, indicating an urgent need of prophylactic vaccines and antivirals. In
recent years, a great deal has been learned about the mechanisms of dengue virus genome amplification. However, little is
known about the process by which the capsid protein recruits the viral genome during encapsidation. Here, we found that
the mature capsid protein in the cytoplasm of dengue virus infected cells accumulates on the surface of ER-derived
organelles named lipid droplets. Mutagenesis analysis using infectious dengue virus clones has identified specific
hydrophobic amino acids, located in the center of the capsid protein, as key elements for lipid droplet association.
Substitutions of amino acid L50 or L54 in the capsid protein disrupted lipid droplet targeting and impaired viral particle
formation. We also report that dengue virus infection increases the number of lipid droplets per cell, suggesting a link
between lipid droplet metabolism and viral replication. In this regard, we found that pharmacological manipulation of the
amount of lipid droplets in the cell can be a means to control dengue virus replication. In addition, we developed a novel
genetic system to dissociate cis-acting RNA replication elements from the capsid coding sequence. Using this system, we
found that mislocalization of a mutated capsid protein decreased viral RNA amplification. We propose that lipid droplets
play multiple roles during the viral life cycle; they could sequester the viral capsid protein early during infection and provide
a scaffold for genome encapsidation.
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Introduction
The genus Flavivirus comprises a large group of emerging and re-
emerging pathogens capable of causing severe human diseases. It
includes yellow fever (YFV), dengue (DENV), West Nile (WNV),
tick borne encephalitis (TBEV), and Japanese encephalitis (JEV)
viruses. DENV is the most significant mosquito borne human viral
pathogen worldwide. It infects more than 50 million people each
year, resulting in around 25,000 deaths. The lack of vaccines and
antivirals against DENV leaves the 2 billion people at risk, mainly
in poor countries, in a constant state of alarm [1].
The replication cycle of different members of the Flavivirus genus
is fundamentally similar. The viral genome is a single plus-
stranded RNA molecule that serves as messenger for viral protein
synthesis, template for RNA amplification, and substrate for
encapsidation [2]. In recent years, a number of cis-acting RNA
elements have been identified in the coding and uncoding regions
of the flavivirus genomes as promoters, enhancers, and cyclization
signals necessary for efficient amplification of the viral RNA (for
review see [3]). A mechanism by which the viral polymerase
specifically recognizes and copies the viral genome has been
recently proposed [4]. In contrast, little is known about the
recognition of the viral RNA by the capsid (C) protein. For
flaviviruses, it is still unclear how, when, and where the C protein
recruits the viral RNA during viral particle morphogenesis. In this
work, we used DENV to investigate how the C protein usurps
cellular organelles to facilitate viral replication.
The flavivirus genomes contain a long ORF encoding a
polyprotein that is cleaved into three structural proteins (C,
prM, and E) and seven nonstructural proteins (NS1-NS2A- NS2B-
NS3-NS4A-NS4B-NS5) [5]. The proteins C and prM are
connected by an internal hydrophobic signal sequence that spans
the ER membrane and is responsible for the translocation of prM
into the ER lumen. The first cleavage is accomplished by the viral
NS3/2B protease, which resides in the cytoplasmic side of the ER
membrane and separates the mature C protein from its membrane
anchor sequence [6–8]. It has been proposed that the mature form
of the C protein remains associated to intracellular membranes via
an internal hydrophobic region conserved in all flaviviruses [9].
In flavivirus infected cells, the C protein was detected both in
the cytoplasm and the nucleus [10–13]. Inside the nucleus it has
been shown to accumulate in the nucleolus. The cytoplasmic
fraction of the C protein of kunjin virus (KUNV) was found near
structures called convoluted membranes in close association with
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A recent report has demonstrated a complex membrane
architecture that links flavivirus genome replication and viral
assembly [16]. A coupling between RNA synthesis and RNA
encapsidation has been also suggested [17]. It was shown that viral
RNAs were not encapsidated if they were not actively synthesized
in the replication complexes. Interestingly, a complex connection
between the encapsidation process and proteins of the RNA
replication machinery is emerging. Specific amino acids changes in
NS2A and NS3 were found to impair particle formation [18–21].
Whether these NS proteins bind to the C protein, to the viral
RNA, or to cellular components (proteins or membranes) is still
unknown.
The mature C is a highly basic protein of 12 kDa that forms
homodimers in solution [22,23]. The first 32 and the last 26
residues of the KUNV C protein were proposed to interact with
the viral RNA [24]. The tridimensional structures of DENV and
WNV C proteins were recently solved by NMR and crystallog-
raphy, respectively [25,26]. These studies indicated that the
monomer contains four alpha helices (a1t oa4). The first 20
amino acids are unstructured in solution and were cleaved in the
WNV C crystals [26]. The first 3 helices (a1t oa3) form a right
handed bundle that comprises the monomer core. The different
orientation of a1 in WNV and DENV suggested that this helix is
flexible. The a4, the longest helix, extends away from the
monomer core and has a high density of basic residues on the
solvent accessible surface, which were proposed to interact with
the viral RNA. On the opposite side of the molecule, the surface
contributed by a22a29 and a12a19 is largely uncharged and is
proposed to interact with membranes [25]. The originally
described internal hydrophobic region, residues 46 to 66 in
DENV C, includes helices a2 and a3 [9]. Although the C protein
is the least conserved of the flavivirus proteins, the structural
properties are very similar and the charge distribution is well
conserved.
Here, we investigated the subcellular localization of the C
protein in DENV infected cells and found that the cytoplasmic C
accumulates around ER-derived organelles called lipid droplets
(LDs). A novel reporter system was developed, which allowed us to
dissociate cis-acting signals for RNA synthesis from the C coding
sequence. Using infectious DENV RNAs and the new reporter
system, specific residues in the a2 helix of the C protein were
identified as crucial determinants for LD localization and DENV
particle formation. Furthermore, we report that pharmacological
inhibition of LD formation greatly decreases DENV replication,
providing new ideas for antiviral strategies.
Results
Lipid droplet localization of DENV C protein in infected
cells
Localization of the C protein in the cytoplasm and the nucleus
of DENV infected cells has been previously reported. The nuclear
localization was carefully analyzed by several groups [12,13]. In
contrast, there is limited information regarding the distribution of
the C protein in the cytoplasm of the infected cell, which is the
place of viral encapsidation. To investigate the subcellular
localization of the C protein during viral replication, DENV2
was used to infect BHK cells. As previously described, when cells
were fixed with methanol and used for indirect immunofluores-
cence, the C protein was found in the nucleus and accumulated in
the nucleolus (Fig. 1A, left panel). Methanol fixation is known to
extract cellular lipids. Therefore, in order to preserve the
membranous structures induced by viral infection, and to
investigate the distribution of C in the cytoplasm, DENV infected
cells were fixed with paraformaldehyde and permeabilized with a
low concentration of Triton X-100. Remarkably, in these
conditions, all the infected cells showed C protein accumulation
in defined spherical structures (Fig. 1A, right panel). Higher
magnification of the images using confocal microscopy revealed
that the C protein was organized in a ring-like pattern (Fig. 1A).
Co-localization of DENV C with ER or Golgi markers was not
observed in these conditions (data not shown). The images of C
labeling after DENV infection resembled the distribution of the
core protein reported for hepatitis C (HCV), which accumulates
on the surface of lipid droplets (LDs) [27–29]. To analyze whether
DENV C associates to these organelles, infected cells were labeled
with antibodies against C and incubated with BODIPY, which
stains neutral lipids in LDs. These studies revealed that most of the
C protein observed was present around LDs (Fig. 1B). Localization
of the C protein surrounding LDs was observed in different DENV
infected human cells such as HepG2 and HeLa (Fig. 1B and data
not shown). In addition, because DENV is a mosquito borne virus,
we examined the localization of C in infected mosquito C6/36
cells. The cytoplasmic localization of C in these cells was also
surrounding LDs (Fig. 1B).
To further study the association of C with LDs, sucrose
gradients were used to separate the LD fraction by flotation. The
presence of C and the adipose differentiation-related protein
(ADRP or adipophilin, LD marker) were detected by western
blots. A fraction of C was detected together with ADRP in LDs
(Fig. 1C). In this fraction the lactate dehydrogenase activity was
not detected, indicating lack of cytosolic contamination. The
amount of C observed in the LD fraction was lower than that
expected according to the co-localization observed with BODIPY
(Fig. 1C). It is possible that the viral protein partially dissociates
during cell disruption and biochemical fractionation. In order to
further analyze the localization of C in the cytoplasm of DENV
infected cells, co-localization of C with ADRP was also
determined. These studies showed the presence of C and ADRP
on LDs (Fig. 1D). Early after infection, we observed single LDs
Author Summary
Dengue virus is the single most significant arthropod-
borne virus pathogen in humans. In spite of the urgent
medical need to control dengue infections, vaccines are
still unavailable, and many aspects of dengue virus biology
and pathogenesis remain elusive. We discovered a link
between dengue virus replication and ER-derived organ-
elles known as lipid droplets (LDs). Dengue infection
increases the amount of LDs per cell and pharmacological
inhibition of LD formation greatly reduces dengue virus
replication. In addition, we have found that the viral capsid
protein in infected cells accumulates on the surface of LDs.
Manipulation of infectious clones and generation of new
reporter dengue viruses allowed us to define the
molecular basis of capsid protein association to LDs.
Specific amino acids on the a2 helix, located in the center
of the capsid protein, were found to be crucial for both
accumulation of capsid protein on LDs and dengue virus
infectious particle formation. We propose that LDs
facilitate viral replication providing a platform for nucle-
ocapsid formation during encapsidation. Our findings
begin to unravel the complex mechanism by which
dengue virus usurps cellular organelles to coordinate
different steps of the viral life cycle.
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containing either C or ADRP were also observed.
LDs are ER-derived organelles that contain a core of neutral
lipids enclosed by a monolayer of phospholipids and exhibit
variable protein content [30]. The metabolism of LDs has
attracted considerable attention due to its link with human
diseases such as obesity, inflammation, and cancer [31,32]. LDs
are found in different cell types in normal conditions. However, it
was noticeable that DENV infection increased the size and the
amount of LDs per cell. Quantitative analysis showed a 3-fold
increase in the amount of LDs in DENV infected cells as
compared with mock infected cells (Fig. 1E). To investigate
whether C was the viral factor responsible for the increase in the
number of LDs, droplets were enumerated in cells expressing only
the C protein. BHK cells were transfected with an expression
vector encoding the mature form of C or a control vector. The
level of expression of the C protein was slightly higher than that
observed in DENV infected cells. Enumeration of droplets
indicated that the viral protein increased about 2-fold the amount
of LDs per cell (Fig. 1F). The higher increase of LDs observed after
DENV infection in respect to that observed in cells expressing only
C could be due to the different source of the protein when it is
produced from the viral polyprotein. In addition, it is possible that
other viral factors or the infection itself affects LD metabolism.
Thus, we evaluated the amount of LDs in DENV replicon-
expressing BHK cells. In this case, the amount of LDs was not
significantly different to that observed in replicon-cured cells (data
not shown).
Figure 1. DENV infected cells accumulate the C protein around lipid droplets. A. Nuclear and cytoplasmic distribution of C protein in DENV
infected BHK cells. Cells were infected with DENV2 and analyzed by immunofluorescence using a polyclonal anti-C antibody. Cells were fixed with
methanol (MeOH) or paraformaldehyde (PFA) as indicated on the top. B. The C protein is targeted to lipid droplets. BHK, HepG2, and C6/36 cells were
infected with DENV2, fixed at 48 h post-infection, probed with anti-C antibodies and BODIPY for lipid droplets staining, and examined by confocal
microscopy. C. Subcellular fractionation of LDs. DENV-infected cell lysates were fractionated into lipid droplets (LD), cytosol (C), and microsome (M)
fractions by sucrose gradient centrifugation. A total cytoplasmic extract was also included (T). The samples were immunoblotted with anti-ADRP and
anti-C antibodies. D. Co-localization of C and ADRP on LDs. DENV infected BHK cells were analyzed by immunofluorescence with anti-ADRP and anti-
C antibodies, and stained with BODIPY. E. DENV infection increases the number of lipid droplets. The amount of lipid droplets in control or DENV
infected BHK cells were determined. Cells were fixed 48 h post- infection, incubated in 1.5% of OsO4, and lipid bodies were enumerated by light
microscopy in 50 consecutive cells in each slide in triplicates. The bars indicate the standard error of the mean (+/2SEM), (P,0.0002). F. Expression of
C protein increases the number of lipid droplets. The amount of lipid droplets in control or C expressing BHK cells were determined as described
above. The bars represent the standard error of the mean (P,0.0001).
doi:10.1371/journal.ppat.1000632.g001
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increased number of droplets observed in DENV-infected cells
provide the first link between these organelles and DENV
replication.
The mature C protein is targeted to LD in the absence of
other viral proteins
During flavivirus polyprotein synthesis, the C protein is targeted
to the ER membrane by the anchor peptide, which is removed by
the viral NS3/2B protease in the cytoplasm and the host signal
peptidase in the ER lumen (Fig. 2A, left panel). To investigate
whether the anchor peptide plays a role in targeting the C protein
to LDs, a full-length genomic DENV cDNA was modified to
include an artificial FMDV2A cleavage site at the C-terminus of
the C protein (DENV-FMDV2A), which would release co-
translationally the mature C protein. Transfection of DENV-
WT or DENV-FMDV2A RNAs into BHK cells resulted in
efficient translation and amplification of viral RNAs (data not
shown). Appropriate cleavage of C by the FMDV 2A was
demonstrated by Western blot analysis of cytoplasmic extracts
Figure 2. The C protein contains the structural determinants for LD targeting. A. Schematic representation of the topology of the viral C
and prM proteins on the ER membrane. The anchor peptide and the cleavage sites of the signal peptidase and viral NS3/2B proteases are indicated.
The location of the FMDV2A protease replacing the NS3/2B site is shown in the scheme on the right. The western blot shows expression of the C
protein in cytoplasmic extracts of cells transfected with a full length DENV RNA WT (Cwt) or the RNA including the FMDV2A site (C2A). B. The anchor
peptide is dispensable for C accumulation on LDs. BHK cells transfected with the DENV-FMDV2A RNA were fixed and probed with antibodies against
C and BODIPY to stain neutral lipids in LDs, as indicated on the top. C. Expression of the mature C protein in the absence of other viral components is
sufficient for LD targeting. BHK cells were transfected with an expression plasmid that encode the mature form of DENV C protein. Twenty four h
post-transfection cells were fixed and probed with anti-C antibodies followed by staining of lipid droplet.
doi:10.1371/journal.ppat.1000632.g002
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(Fig. 2A, right panel). As expected, DENV-FMDV2A RNA
produced a C protein about 2 kDa larger than the WT protein,
corresponding to C plus 19 amino acids of the FMDV2A (Fig. 2A,
C2A). Confocal microscopy analysis indicated that the prema-
turely processed C protein localized almost exclusively around
LDs, indicating that the anchor peptide that targets the C protein
to ER membranes during polyprotein synthesis is not required for
protein C localization on LDs (Fig. 2B).
To determine whether C association to LDs requires other viral
components, the mature C protein was expressed using a plasmid
under control of the CMV promoter in BHK cells. Cells were
analyzed by immunofluorescence using anti-C antibodies and
stained with BODIPY at 10, 24 and 48 h post-transfection.
Although the level of mature C protein expressed in BHK cells was
higher than that observed after DENV infection, most of the
expressed C protein also accumulated around LDs (Fig. 2C). This
analysis indicates that the mature C protein, in the absence of
other viral components, is able to associate to LDs.
Specific amino acids in the a2 helix are involved in C
association to LDs
The molecular basis of C protein association to LDs was then
investigated. To this end, we used the model proposed for DENV
C interaction with cellular membranes based on the structural
information previously obtained by NMR [25]. The model
implicates a concave shaped hydrophobic cleft including amino
acids of a1 and a2 helices and the connecting loop (Fig. 3A, left
panel). We also considered the information provided in previous
analysis describing a flavivirus conserved internal hydrophobic
region, spanning amino acids 46 to 66 (a2 and a3) in DENV,
which was proposed to interact with ER membranes [9]. Amino
acids substitutions of residues around the hydrophobic cleft were
designed in the context of the full length DENV genome as
described in Fig. 3A, and localization of the C protein was
followed by confocal microscopy after RNA transfection. Substi-
tutions of uncharged amino acids in a1 helix or in the a1–a2
connecting loop resulted in C proteins that accumulated in LDs,
similar to that observed with the WT virus (Fig. 3B). In addition,
deletion of the complete a2 helix or substitution of hydrophobic
amino acids within a3 resulted in the synthesis of an unstable C
protein that was barely detected by immunofluorescence (data not
shown). Interestingly, a substitution of the two hydrophobic
residues (L50 and L54) within a2 that are facing outwards from
the a22a29 plane, rendered a C protein that was distributed
throughout the cytoplasm without evident association to LDs
(Fig. 3B, Mut a2), providing evidence of an important role of these
amino acids in C protein-membrane association.
To better define the role of L50 and L54 on C targeting to LDs,
we designed the individual mutants L50S (Mut a2.1) and L54S
(Mut a2.2). Localization of C after RNA transfection showed a
defect in the distribution of these proteins in the cytoplasm when
compared with the WT (Fig. 3C). We observed the presence of
Mut a2.1 and Mut a2.2 C proteins throughout the cytoplasm;
however, in contrast to that observed with the Mut a2, small
patches of Mut a2.1 and Mut a2.2 C proteins were detected on
LDs (Fig. 3C). These results indicate that both amino acids, L50
and L54, are necessary for proper targeting of C to LDs.
Mutant a2 retains the ability to bind RNA and to dimerize
in solution
To investigate whether the mutation L50S–L54S alters C
protein folding, dimerization, or RNA binding, biochemical
properties of the recombinant proteins were analyzed. The mature
WT and mutated C proteins were cloned in an expression vector
in the absence of a tag. Purification was performed by heparin
columns and gel filtration. Expression and purification of the
CL50SL54S mutant were indistinguishable from the WT protein
(Fig. 4A). The oligomerization state of the proteins was determined
by size exclusion chromatography and light scattering. Single picks
corresponding to molecular weights of 23.8 and 24.9 kDa were
obtained for the CWT and the CL50SL54S respectively, which are
consistent with dimer formation.
To determine whether the mutation could interfere with the
ability of the C protein to bind RNA, mobility shift and filter
binding assays were performed to estimate the dissociation
constants. A radiolabeled RNA was used for titration with
different concentrations of CWT or CL50SL54S. The dissociation
constants were not significantly different, 22 nM and 20 nM for
the WT and the mutant, respectively (Fig. 4B and 4C). The results
indicate that the L50S–L54S mutation introduced in the C protein
did not alter protein folding or other known properties of the
protein.
Association of C to LDs is necessary for DENV replication
To investigate the effect of mutating C on DENV replication,
cells were transfected with WT or mutant RNAs that produce
stable C proteins (Mut a1, Mut a1–a2 loop, Mut a2, Mut a2.1,
and Mut a2.2). Viral replication in transfected cells was evaluated
by immunofluorescence as a function of time and by assessing the
production of infectious viral particles by plaque assay. Mut a1
and Mut a1–a2 loop produced titers similar to the WT at 24, 48
and 72 h (Fig. 5A). After 96 h the titers decreased due to extensive
cytopathic effect and death of the transfected cells. In contrast, the
titers for Mut a2.1 and Mut a2.2 were about two orders of
magnitude lower than that for the parental virus. In addition, no
viral particles were detected in the supernatants of cells transfected
with Mut a2 up to 5 days post-transfection (Fig. 5A). Furthermore,
the immunofluorescence assays indicated that while the WT, Mut
a1, and Mut a1–a2 loop showed the complete monolayer antigen-
positive for DENV at day 3, Mut a2.1 and Mut a2.2 showed a
propagation delay, and no viral propagation was detected in cells
transfected with Mut a2 until day 15 (data not shown). The results
indicate that mutations that alter C targeting to LDs produced
defects in viral replication.
To investigate whether the viruses carrying the mutations in the
a2 helix produced viral particles that were not infectious, we
determined the presence of the viral envelope (E) protein in the
media. Western blot analysis indicated that the amount of the E
protein released from cells transfected with Mut a2.1 and a2.2 was
less than 5% of that observed with the WT (Fig. 5B). In addition,
the E protein was undetectable in the media of cells transfected
with Mut a2 RNA. Moreover, viral RNA was quantified in the
media of cells infected with WT, Mut a2.1, and a2.2 using real
time RT-PCR (Fig. 5C). The amount of viral RNA detected for
both mutants was about two logs lower than that for the parental
virus, which correlated with the amount of infectious particles
produced in Fig. 5A. These results indicate that the mutations in
the a2 helix of the C protein impair the production of DENV
particles.
Dissecting cis-acting RNA replication signals from the C
coding sequence
We have recently developed a DENV reporter system to
evaluate each step of DENV replication [33]. To further
characterize the defect of the DENV C mutants, we introduced
the substitutions in the reporter virus (DV-R). Controls and
Lipid Droplets Are Necessary for DENV Production
PLoS Pathogens | www.plospathogens.org 5 October 2009 | Volume 5 | Issue 10 | e1000632Figure 3. Amino acids within the a2 helix of C are necessary to direct the protein to LDs. A. Ribbon diagram of the dimer structure of
DENV C protein [25]. The four a helices (a1t oa4) are indicated in each monomer. The hydrophobic cleft proposed to interact with membranes is also
shown. On the right, the location of amino acids that were mutated in the DENV infectious clone is indicated in the structure (Mut a1, Mut a1–a2
loop, and Mut a2). B. Distribution of the C protein and lipid droplets in cells transfected with mutated DENV RNAs. BHK cells transfected with the WT
or mutated RNAs containing the substitutions indicated in A were analyzed by immunofluorescence and confocal microscopy. The C protein and lipid
droplets were localized by anti-C antibodies (green) and BODIPY (red), respectively. C. Amino acids L50 and L54 are necessary for targeting C to LDs.
BHK cells transfected with DENV RNAs carrying the individual substitutions L50S (Mut a2.1) or L54S (Mut a2.2) were used to analyze the localization of
the mutated C proteins and LDs as described above.
doi:10.1371/journal.ppat.1000632.g003
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activity was monitored as a function of time as previously reported
[33]. Unexpectedly, transfection of Mut a2 DV-R showed a
delayed increase in luciferase activity during viral RNA synthesis
(data not shown). Because flavivirus structural proteins do not
participate in viral RNA amplification [34,35], this observation
was puzzling. It is possible that the substitution introduced in the
a2 helix alters RNA structures present in the C coding sequence
that have been previously reported to be involved in genome
cyclization and RNA amplification [3]. In fact, the presence of
overlapping signals in the viral genome has been a limitation in
studying the effect of mutations in the N-terminus of C on viral
encapsidation. Thus, to properly analyze the defects in replication
of DENV C mutants, we designed a new DENV reporter system
dissociating the cis-acting signals from the C coding region. To this
end, we introduced a duplication of the first 104 nucleotides of the
C coding region, called here the cis-acting element CAE (including
the previously described cHP and the cyclization sequence 59CS)
[36–38]. The CAE was fused to the luciferase coding region
followed by the complete DENV ORF (Fig. 6A, monocistronic
DENV reporter, mDV-R). Between the luciferase and the DENV
structural proteins an FMDV2A protease was introduced to
ensure the release of the reporter protein. In summary, the new
reporter DENV contained a physical separation of the CAE
sequences and the C coding region. Transfection of the mDV-R
RNA resulted in efficient viral replication and production of
infectious viral particles (Fig. 6B and C, WT).
To investigate the replication of mutants in the a2 helix that
impair LD association without altering the cis-acting RNA
elements, Mut a2, Mut a2.1, and Mut a2.2 were introduced in
the mDV-R. The RNAs corresponding to the mDV-R WT, the
three mutants in the a2 helix, the propagation impaired mutant
containing the complete deletion of C coding sequence (Mut DC),
or the replication impaired mutant carrying a substitution in the
polymerase NS5 (Mut NS5), were transfected into BHK cells
(Fig. 6B). The Mut DC mDV-R showed luciferase levels at 24 and
48 h post-transfection that were indistinguishable from the WT
mDV-R levels, confirming that the C protein is dispensable for
RNA synthesis and indicating that the duplication of the CAE was
fully functional (Fig. 6B, compare Mut DC with the positive and
negative controls, WT and Mut NS5, respectively). Similarly, Mut
a2.1 and Mut a2.2 translated and replicated the RNA efficiently.
In contrast, while the Mut a2 RNA was translated as the parental
RNA (see luciferase activity at 4 h post-transfection), the luciferase
levels detected at 24 and 48 h were reduced about 40 fold in
respect to the WT control (Fig. 6B). These results indicate that
while deletion of the complete C protein or the individual
mutations L50S and L54S did not affect DENV RNA synthesis,
the more drastic change that included both substitutions did, and
this effect was not due to alteration of the cis-acting elements.
To analyze the ability of the mutants in the C protein to
produce reporter infectious particles, we collected the supernatants
of the transfected cells as a function of time and used them to infect
fresh BHK cells. As expected, the luciferase activity in cells
infected with the media obtained from cells transfected with Mut
DC was undetectable (Fig. 6C). Similarly, the Mut a2 failed to
produce viral particles. After infection with the media of cells
transfected with Mut a2.1 or Mut a2.2, between 50 and 200 fold
lower luciferase activity than that with WT mDV-R was observed.
These results confirm a direct role of amino acids L50 and L54 on
viral particle formation.
The decreased level of RNA amplification of Mut a2 presented
in Fig. 6B was unexplained; thus, we decided to further analyze
this observation. Knowing that the C protein has high affinity for
RNA molecules, a plausible explanation could be that a
mistargeted C protein, which accumulates in the cytoplasm,
prematurely binds the viral RNA or interacts with other factor
involved in viral RNA replication. To analyze this possibility, we
studied the RNA synthesis of WT DENV in cells producing the
WT or mutated C proteins in trans. BHK cells expressing a
Figure 4. Biochemical properties of recombinant C protein with
substitution L50S–L54S. A. High expression levels and dimerization
of CWT and CL50S–L54S. SDS-PAGE stained with coomassie blue showing
similar expression levels of the recombinant proteins. The molecular
mass obtained by size exclusion chromatography (SEC) and light
scattering for both proteins are indicated. B. Interaction of CWT and
CL50S–L54S with the DENV 59UTR RNA probe monitored by filter binding
assay. Uniformly
32P labeled RNA (0.1 nM) was incubated with
increasing concentrations of the respective C protein. Bound indicates
RNA-protein complexes retained in the nitrocellulose membrane and
free denotes the unbound probes retained in the nylon membrane. The
RNA probes bound and free in each membrane were visualized by
PhosphoImaging. C. Quantification of the percentage of RNA probe
bound was plotted as a function of C concentration and fitted using
equation 1 (see Materials and methods). The dissociation constants Kds
are indicated inside the plot.
doi:10.1371/journal.ppat.1000632.g004
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reporter DENV RNA, and luciferase activity was monitored as a
function of time. Over-expression of CWT or CL50SL54S proteins
was not toxic for BHK cells as determined by MTS assays. Cells
expressing CWT showed accumulation of the viral protein in LDs,
while the ones expressing CL50SL54S showed a cytoplasmic
distribution without a significant accumulation in LDs (Fig. 6D,
right panel). Luciferase activity was determined in cells at 4, 24, 48
and 72 h post-transfection (Fig. 6D). Cells expressing the CWT
showed luciferase levels at 48 and 72 h about 10 and 30 fold
higher, respectively, than those in cells expressing the CL50SL54S.
These results suggest that the mutated protein expressed in trans
was able to decrease the level of viral RNA amplification.
Taken together, the new reporter DENV allowed us to
dissociate the processes of RNA replication and encapsidation,
demonstrated that C is dispensable for RNA synthesis, and
confirmed an important role of amino acids L50 and L54 in viral
particle formation. In addition, the results suggest that a
mislocalized C protein could interfere with viral RNA synthesis,
providing evidence for a possible role of LDs in coordinating
different viral processes.
LDs as target for DENV inhibition
Here, we found that targeting C protein to LDs is necessary for
DENV particles formation. In addition, we observed that viral
infection increases the amount of LDs. Based on these findings, we
hypothesized that interfering with LDs formation/metabolism
could be a means for antiviral intervention. To prove this idea, we
used a fatty acid synthase inhibitor (C75) that was previously
designed for obesity control [39–41]. It has been reported that this
drug reduces the amount of LDs in the cell and inhibits pre-
adipocyte differentiation. First, we analyzed the effect of C75 on
the amount of LDs in DENV-infected and non-infected cells. The
concentration of drug used was determined to be non-toxic for
BHK cells (data not shown). Quantitative analyses of LDs in BHK
cells showed that concentrations between 10 and 20 mM of drug
decreased the amount of LD in DENV-infected and mock-infected
cells (Fig. 7A). To determine the effect of C75 on viral replication,
cells were treated with 10 and 20 mM of compound, infected with
DENV2 using a multiplicity of infection of 1, and viral titers were
determined at 24 and 48 h post-infection by plaque assay (Fig. 7B).
Using 20 mM of C75, a drop in two orders of magnitude in the
viral titer at 48 h and complete inhibition of viral replication at
24 h were observed. Similar results were obtained when C75
treated HepG2 cells were infected with DENV (data not shown).
To determine how the drug affects each step of viral replication,
the reporter DENV was used. Luciferase activity was measured in
extracts of BHK cells infected with mDV-R in the presence or
absence of C75. At 10 h post-infection the luciferase levels were
unaffected by the inhibitor, suggesting that the drug was not
Figure 5. Targeting the C protein to LDs is necessary for DENV production. A. The media of BHK cells transfected with DENV RNA WT or
mutants (Mut a1, Mut a1–a2 loop, Mut a2, Mut a2.1, and Mut a2.2) were collected as a function of time post-transfection and used to quantify the
amount of infectious particles by plaque assay in BHK cells. The plot indicates the plaque forming units per ml at different times post-transfection. B.
The secreted enveloped protein E was analyzed in the supernatant of transfected cells by western blot as previously described [33]. C. BHK cells were
infected with a multiplicity of infection of 0.1 of WT, Mut a2.1, and Mut a2.2 viruses. The viral RNA was quantified by real time RT-PCR in the media
obtained 24 h post-infection.
doi:10.1371/journal.ppat.1000632.g005
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and 48 h post-infection a reduction of luciferase levels of about 4-
fold was observed, which corresponds to a decrease in RNA
amplification. To investigate the effect of the drug on infectious
viral particle formation, the media from cells subjected to each
treatment was collected 48 h after infection and used to infect
fresh cells in the absence of C75. At this time, an inhibition of
more than 1000-fold was observed, indicating a profound effect of
C75 on viral particle production (Fig. 7D). These results indicate
that altering the LD metabolism can be a means to block DENV
replication.
Discussion
Genome packaging is one of the most obscure steps of the
flavivirus life cycle. Here, we provide the first evidence linking
DENV particle formation with ER derived LDs. We found that
DENV infected cells accumulate the C protein around LDs and
this localization is crucial for infectious particle formation. Specific
hydrophobic amino acids were identified as key determinants for
LD association. In addition, we developed a new genetic tool to
exclude cis-acting RNA replication signals from the C coding
sequence. Using this system, we found that mislocalization of a
mutated C protein interferes with DENV RNA synthesis. Our
studies support the idea that DENV exploits LDs for multiple
purposes during DENV replication. Furthermore, relevant to the
urgent need for antiviral strategies against DENV, we report that
pharmacologic alteration of LD metabolism also inhibits DENV
replication in cell culture.
Structural features of Flaviviridae C proteins and their
association to LD
Flavivirus is one of the three genera of the Flaviviridae family
together with the Hepaci- and Pestivirus [2]. The C proteins of the
three genera do not exhibit significant sequence homology or
common domain organization. However, they are all dimeric,
basic proteins with an overall helical fold, responsible for genome
packaging. In addition, a recent report has suggested a common
RNA chaperone activity for these C proteins [42]. Hepacivirus
mature core proteins are about 170 amino acids in length and
consist of two domains, a highly basic N-terminal domain (D1) and
a hydrophobic C-terminal domain (D2) [43]. In contrast, pesti-
and flavivirus C proteins are shorter, between 90 to 100 residues,
lacking a D2 domain. Compelling evidence has been accumulated
in recent years supporting the idea that HCV particle formation
requires C protein association to LDs, and that the D2 domain is
responsible for targeting C to this organelle [28,29,44–49].
Because the flavivirus C proteins lack a D2 domain, an association
of DENV C protein to LDs was unexpected.
Using DENV-infected cells, we found that the C protein
accumulated on LDs. Hydrophobic residues in the a2 helix of
DENV C were defined as important determinants for LD
association and viral particle formation. In contrast, mutations of
uncharged residues in a1 helix or in the connecting loop between
a1 and a2 helices did not alter LD association or viral
propagation. The importance of an internal hydrophobic region
Figure 6. A new reporter virus that allows dissociation of cis-
acting RNA elements from the capsid coding region confirms a
role of L50 and L54 in DENV particle formation. A. Construction
of a novel monocistronic DENV reporter system. At the top, schematic
representation of the cis-acting replication elements located at the 59
end of the DENV genome. The promoter stem-loop A (SLA), the
cyclization sequence upstream of the AUG (59UAR), the replication
element cHP, and the cyclization sequence 59CS are indicated. In the
middle, the corresponding region of DENV polyprotein is shown. At the
bottom, a schematic representation of the monocistronic DENV
reporter construct (mDV-R) showing the duplication of the cis-acting
elements (CAE) and the location of the luciferase and the viral proteins.
B. Translation and replication of mutant mDV-R RNAs. BHK cells were
transfected with DENV RNAs corresponding to the mDV-R WT, Mut DC
with the complete deletion of C coding sequence, Mut a2.1, Mut a2.2,
Mut a2, and Mut NS5, which carries a mutation in the catalytic GDD
motif of the viral polymerase. Luciferase activity was measured as a
function of time for each RNA as indicated at the bottom. C. Mutations
in the a2 helix of the C protein impair viral particle formation. The
media of the transfected cells from the experiment shown in B was
collected at the indicated times and used to infect fresh cells. Luciferase
activity was measured 48 h post-infection for each virus as indicated at
the bottom. D. A matured form of CL50SL54S protein expressed in BHK
cells decreased the levels of DENV RNA synthesis. Immunofluorescence
of BHK cells expressing the DENV CWT or CL50SL54S probed with anti C
(green) and stained with Bodipy (red) for lipid droplets are shown in the
right panel. The cells transfected with DV-R RNA WT were used to
measure luciferase activity as a function of time, as indicated in the left
panel.
doi:10.1371/journal.ppat.1000632.g006
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more recently was reported to be necessary for efficient
propagation of different flaviviruses [9,50–52]. A recent study
using WNV reported that deletions within the most hydrophobic
section of a2 helix (LALLAFF) impaired viral propagation [53].
However, pseudorevertants with extended deletions of C from
amino acid 40 to 76 were recovered in culture. These results
indicated that a large deletion of about 36 amino acids was better
tolerated than 4–7 amino acid deletions in the hydrophobic
region, suggesting that a short version of the C protein could form
nucleocapsids by an alternative mechanism. A remarkable
functional flexibility of the C protein was observed in TBEV, in
which deletions from 19 to 30 residues were rescued by second site
mutations increasing the hydrophobicity of the protein [51,54].
Studies using a YF replicon trans-packaging system demonstrated
that large deletions in the N and C terminal regions of protein C
were tolerated [50]. In the same report, using a YFV infectious
clone, it was shown that the C protein with deletions of the a1
helix resulted in small plaque phenotypes, while deletions
including a1 and a2 were lethal. Using DENV, we observed that
mutations of amino acids L50 or L54 within a2 helix of C greatly
decrease viral particle formation. These results are in agreement
with a previous study, in which a deletion of residues 42 to 59 in
DENV C protein in a2 impaired viral propagation [52].
According to our findings, hydrophobic amino acids within the
a2 helix in the center of DENV C protein would function as the
hepacivirus C- terminus D2 domain in targeting the protein to
LDs. We conclude that hepaci- and flaviviruses use distinct
structural features of the C protein for subcellular localization,
suggesting a convergent evolution of these viral proteins. It
remains to be examined whether the pestivirus C proteins also
accumulate on LDs.
Biological significance of LD in DENV replication
Viral infection could modulate a range of host cell functions and
usurp the cellular organization to facilitate viral spread. Although
viral translation, RNA amplification, and encapsidation must be
temporally and spatially regulated in the cytoplasm of the infected
Figure 7. Pharmacological inhibition of lipid droplets accumulation impairs DENV replication. A. Effect of C75 on the amount of lipid
droplets in BHK cells. The amount of lipid droplets was quantified in BHK cells treated with different concentrations of C75. Control or DENV infected
BHK cells were used. B. Inhibition of DENV replication in cells treated with C75. The amount of infectious viral particles produced at 24 and 48 h post-
infection in BHK cells were evaluated by plaque assays in control or C75 treated cells as indicated. Error bars indicate the SD of three independent
experiments. C. Effect of C75 on each step of the replication of the mDV-R. Viral stocks of the reporter mDV-R were used to infect BHK cells in the
presence and absence C75. Luciferase activity was evaluated at 10 h post-infection to evaluate entry and translation (left panel), and at 24 and 48 h
to evaluate RNA synthesis (right panel). D. The production of infectious viral particles produced in the experiment described in C was evaluated by
infecting fresh BHK cells in the absence of the inhibitor, and assessing the luciferase activity 48 h after infection.
doi:10.1371/journal.ppat.1000632.g007
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processes are still unclear. Here, we constructed a new genetic
tool to dissociate overlapping signals for DENV RNA replication
and encapsidation (mDVR, Fig. 6A). This tool allowed us to
confirm that complete deletion of the C protein did not alter viral
RNA translation or RNA synthesis. The substitution L50S or
L54S, which altered C targeting to LDs, resulted in viruses that
translated and replicated the RNA efficiently but had defects in
infectious particle production (Fig. 6B and C). These viruses
released reduced amounts of viral E protein and viral RNA,
supporting the idea that C association to LDs is necessary for viral
particle formation (Fig. 5). The double mutant (L50S+L54S),
which abolished protein association to LDs and impaired viral
particle production, was also found to delay amplification of viral
RNA (Fig. 6B, Mut a2). It is possible that accumulation of this
mutated C protein in the cytoplasm could interact with the viral
RNA and interfere with genome amplification. A biological role of
LDs as transient depots to store or sequester proteins that are in
temporary excess has been previously reported [55]. Sequestration
of histones on LDs that are released during development has been
demonstrated [55]. Therefore, similarly to that observed with
histones, LDs could temporally control viral processes by
regulating the availability of the highly basic C protein in the
cytoplasm of infected cells. Interestingly, localization of C on LDs
was also observed in mosquito cells, suggesting a conserved
function of these organelles in viral replication in different hosts.
The place and the mechanism by which the C protein recruits
the viral RNA to form the nucleocapsid in the infected cell are still
unclear. Because a dynamic shift of proteins and lipids between the
ER and the LDs has been reported (for review see [30]), it is
possible that C is stored on LDs early during infection to be then
mobilized to the ER membrane for particle morphogenesis.
Alternatively, the genomic RNA could interact with C on the
surface of LDs to form the nucleocapsids, which could be then
transferred to the ER membrane for new viral particles formation.
We observed that DENV infection increases the amount of LDs
per cell (Fig. 1C). A recent functional genomic screen revealed a
number of genes involved in LD formation and the regulation of
their number, morphology, and distribution in the cell [56]. Thus,
it will be important to investigate how DENV alters these
pathways to increase the formation of new LDs or change the half
life of the already existing ones. In addition, it will be interesting to
examine the effect of the C protein on the enzymatic activities
involved in lipid metabolism that have been found associated to
LDs. In the case of HCV, interaction of the C protein with LDs
was linked to increased lipid accumulation and hepatic steatosis in
transgenic mice [57,58]. Because liver steatosis has been also
observed in DENV-infected mice and fatal cases of DHF in
humans [59,60], it is relevant to investigate a possible correlation
between LD accumulation in infected tissues and DENV
pathogenesis.
The properties of LDs have attracted considerable interest
because of the link between enhanced fat storage and human
diseases such as obesity, inflammation, and cancer. In recent years
different compounds that affect the accumulation and metabolism
of LDs have been developed [61–63]. Here, we found that a fatty
acid synthase inhibitor (C75) that decreased the amount of LDs in
DENV-infected and uninfected cells, also inhibited dengue
replication 100 to 1000 fold (Fig. 7B). Using a luciferase DENV
reporter system, we observed that C75 did not alter viral entry or
viral translation. Although the most pronounced inhibition was
observed in the production of infectious viral particle, a low but
significant reduction of RNA synthesis was also detected. This
effect could be due to alteration of the metabolism of lipids, which
are components of the replication complexes. In addition, the
decreased amount of LDs observed with C75 could account for
the large reduction in viral particles produced.
Currently, dengue fever and dengue hemorrhagic fever are a
tremendous social and economic burden on the world population.
We believe that uncovering molecular details of the DENV life
cycle and understanding the host pathogen interaction will aid the
search for novel anti-dengue strategies.
Materials and Methods
Ethics statement
Research involving animals was approved by the IACUC of the
Leloir Institute fully complying with the National Institute of
Health (NIH, USA) guidelines.
Cells and viruses
Baby hamster kidney cells (BHK-21) were cultured in minimum
essential medium alpha supplemented with 10% fetal bovine
serum, 100 U/ml penicillin, 100 mg/ml streptomycin. Human
hepatocellular liver carcinoma cell line (HepG2) was cultured in
minimum essential medium supplemented with 10% fetal bovine
serum, 100 U/ml penicillin, 100 mg/ml streptomycin and 0.01%
sodium pyruvate. C6/36 HT mosquito cells from A. albopictus,
adapted to grow at 33uC, were cultured in L-15 Medium
(Leibovitz) supplemented with 0.3% tryptose phosphate broth,
0.02% glutamine, 1% MEM non-essential amino acids solution
and 5% fetal bovine serum. Stocks of DENV serotype 2 16681
were prepared in mosquito C6/36 cells and used to infect the
different cell lines as indicated in each case.
Construction of recombinant DENVs
The desired mutations were introduced in a DENV type 2
cDNA clone [64] (GenBank accession number U87411) by
replacing the SacI-SphI fragment of the WT plasmid with the
respective fragment derived from an overlapping PCR. The
sequence of the oligonucleotides used as primers for all the PCR
reactions are listed in Table 1. To generate the plasmids carrying
the mutations L50S, L54S, L50S–L54S, L36S–L39S and V26S–
L29S, common outside primers 101 and 239 were used. Mutation
L50S was generated using the inside primers 1035 and 1036,
mutation L54S using primers 1037 and 1038, mutation L50S–
L54S using primers 833 and 832, mutation L36S–L39S with
primers 1050 and 1049, and mutation V26S–L29S with primers
1054 and 1053.
Bicistronic dengue virus reporter constructs (DV-R) containing
the reporter Renilla luciferase was previously described [33]. The
monocistronic DENV reporter construct was build using a
previously described plasmid pD2/ICAflII [35] including an
additional NotI restriction site at nucleotide 244 (pD2/ICAflII-
NotI). To facilitate insertion of the Renilla luciferase gene (Rluc), we
generated an intermediate plasmid derived from pRL-CMV
(Promega). Using unique SacI and BstBI restriction sites, we
introduced the complete DENV 59UTR followed by the first 104
nucleotides of the coding sequence of C, using primers 101 and 7.
The resulting plasmid was used to introduce downstream of Rluc
the FMDV2A protease coding sequence (QLLNFDLLKLAGD-
VESNPGP) fused to the capsid protein. The fragment carrying
FMDV2A fused to DENV sequences was generated by overlap-
ping PCR using for the first PCR primers 273 and 516, and for the
second PCR primers 517 and 241. The overlapping PCR product
was digested with SacI-NotI restriction enzymes and introduced
into homologous restriction sites within pD2/ICAflII-NotI. To
generate mDV-R Mut L50S, mDV-R Mut L54S, and mDV-R
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common primers 595 and 239. The sense and antisense primers
used to generate each of the mutations were the same as described
above. For mutant mDV-R DC, a fragment carrying the deletion
of mature C protein was generated by overlapping PCR using the
following primers: PCR1 primer sense 595 and primer antisense
1030; and PCR2 primer sense 1031 and primer antisense 239.
The overlapping PCR product was cloned into the mDV-R cDNA
using the unique restriction sites SacI-SphI.
RNA transcription, transfection, and viral recovery
Wild-type (WT) or mutant DENV plasmids were linearized with
XbaI and used as templates for T7 RNA polymerase transcription
in the presence of m7GpppA cap analog. RNA transcripts (5 mg)
were transfected with Lipofectamine 2000 (Invitrogen) into BHK-
21 or HepG2 cells grown in 60-mm-diameter tissue culture dishes.
Supernatants were harvested at the indicated times post-
transfection and used to quantify infectious DENV particles by
plaque assays as previously described [35]. Quantification of viral
RNA was performed by real time RT-PCR using TaqMan
technology as previously described [35].
Immunofluorescence assay
BHK-21, HepG2, and C6/36 cells were seeded into 24-well
plates containing glass coverslips. Twenty four hours after, they
were infected with a DENV2 stock using a multiplicity of infection
of 10. At the indicated times the coverslips were removed and the
cells were fixed in paraformaldehyde 4%, sucrose 4%, PBS pH 7.4
at room temperature for 20 minutes. Alternatively, they were fixed
in methanol for 20 minutes at 220uC. Cells were then permeated
with 0.1% Triton X-100 for 4 minutes at room temperature.
Rabbit polyclonal antibodies against C were obtained in our
laboratory as describe below. A 1:1000 dilution of this anti-C
antibody in PBS–0.2% gelatin was used. Goat anti-rabbit IgG Cy3
conjugated (Jackson Immuno Research) were used at 1:500
dilution. For lipid droplets staining cells were incubated with
BODIPY 493/503 (4,4-difluoro 1,3,5,7,8 pentamethyl 4-bora
3a,4a-diaza-s-indacene) (Molecular Probes) at 1:500 dilution,
1 mM. For detection of ADRP, a commercial mouse monoclonal
antibody (ARP American Research Products, Inc) was used 1/100
in PBS-gelatine. Cy5 AffiniPure Donkey Anti-mouse IgG antibody
(Jackson ImmunoReserch) was used 1/500 in PBS-gelatine. Cells
were mounted on glass slides and images were obtained with a
Zeiss axioplant confocal microscopy. To maintain the consistency
of the green color for the C protein, the color of BODIPY was
changed to red. For immunofluorescence of transfected cells, the
procedure was the same as the one described for infections.
Purification of recombinant C protein in E. coli and
production of antibodies
The coding sequences of the mature C protein (amino acids 1–
100) were obtained by PCR from the DENV type 2 cDNA clone
[64] using the sense primer 487 carrying the restriction site NcoIa n d
the antisense primer 489 with the restriction site BamHI. The PCR
product was digested and cloned into the expression vector pET-
15b (Novagen). Protein expression was performed in the E. coli
strain BL21 Rosetta (DE3)pLysS (Novagen). The bacterial culture
was grown at 37uC until OD600=1, induced with 1 mM IPTG and
incubated at 18uC overnight. C protein from soluble fraction was
first purified using heparin affinity chromatography, eluted with a
gradient from 0.2 M to 2 M of NaCl in 50 mM NaH2PO4
(pH 7.5). Fractions containing the protein were collected and
further purified by size exclusion chromatography using a Superdex
75 column (GE Healthcare). Highly purified fractions of C protein
were aliquoted and stored at 270uC in eluted buffer containing
200 mM NaH2PO4 (pH 6) and 500 mM NaCl. Polyclonal
antibodies were obtained by inoculating rabbits three times with
0.2 mg of the purified C protein with Freund’s adjuvant (SIGMA).
Four days before sacrificing the animals, a booster of C without the
adjuvant was injected. The antibodies obtained were evaluated for
specificity using western blots and ELISA employing infected and
non-infected BHK cell extracts and supernatants.
Eukaryotic expression of mature C protein
The coding sequences of the mature C protein (amino acids 1 to
100) derived from DENV type 2 were obtained by PCR using the
sense primer 947 carrying the restriction site AflII and the
antisense primer 489 with the restriction site BamHI. The PCR
product was digested and cloned in the eukaryotic expression
plasmid pcDNA6/V5-HisB (Invitrogen). Purified plasmid (2 mg)
was transfected with Lipofectamine 2000 (Invitrogen) into BHK-
21 cells grown in 24-well plates containing a 1-cm
2 coverslip. At
different time points after transfection the coverslips were fixed
and directly used for IFA.
Lipid droplet counting
Cells were fixed as described for the immunofluorescence assay
and then treated as follows: rinsed in 0.1 M cacodylate buffer,
Table 1. Sequence of oligonucleotides.
# Sequence
7 GTGGGTTCGAAAGTGAGAATCTCTTTGTCAGCT
101 TCCAGACTTTACGAAACACG
239 TCTGTGAT GGAACTCTGTGG
241 TTTGACATTCCTATGCAACG
273 GAATTCGAGCTCACGCGTAAATTTAATACGACTCACTATAAGTTG-
TTAGTCTACGTGG
487 ATCTCTGCCATGGGTAATAACCAACGGAAAAAGGCG
489 TGCAGAGGATCCTCATTATCTGCGTCTCCTATTCAAGATG
516 GACGTCTCCCGCAAGCTTGAGAAGGTCAAAATTCAACAGCTGTT-
GTTCATTTTTGAGAACTCGC
517 CTTCTCAAGCTTGCGGGAGACGTCGAGTCCAACCCTGGGCCAAT-
GAATAACCAACGGAAAAAGGCG
595 GTGATGATTTACCAAAAATGTTTATTGAATCGG
832 GGAAACGTGAGAACGCCACTGAGGCCATGAACAGTTTTAATGG
833 CATGGCCTCAGTGGCGTTCTCACGTTTCCTA ACAATCCCACC
947 ATCTCTCTTAAGATGAATAACCAACGGAAAAAGG
1030 GGCAAGCTTGAGTAAATCAAAATTTAGGAGCTGTTGTTCATTTTT-
GAGAACC
1031 TTCTCAAAAATGAACAACAGCTCCTAAATTTTGATTT ACTCAAGC-
TTGCCGGC
1035 GGAAACGAAGGAACGCCACTGAGGCCATGAACAGTTTTAATGG
1036 CATGGCCTCAGTGGCGTTCCTTCGTTTCCTAACAATCCCACC
1037 GGAAACGTGAGAACGCCACCAGGGCCATGAACAGTTTTAATGG
1038 CATGGCCCTGGTGGCGTTCTCACGTTTCCTAACAATCCCACC
1049 CGTCCCTGTGACATTCCCGATGAGAATCTCTTTGTCAG
1050 GAGATTCTCATCGGGAATGTCACAGGGACGAGGACC
1054 CCGCGTGTCGACTTCACAACAGTCAACAAAGAGATTCTCACTTGG
1053 CTCTTTGTTGACTGTTGTGAAGTCGACACGCGGTTTCTCTCGC
doi:10.1371/journal.ppat.1000632.t001
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1.0% thiocarbohydrazide (5 min), rinsed in 0.1 M cacodylate
buffer, incubated in 1.5% OsO4 (3 min), rinsed in distilled water,
and then dried for further analyses. The morphology of fixed cells
was observed, and lipid droplets were enumerated by light
microscopy with 6100 objective lens. The total amount of lipid
droplets was counted in 50 consecutive cells. For each determi-
nation the experiment was done in triplicates.
Isolation of lipid droplets by subcellular fractionation
Lipid droplets were isolated by sucrose gradients as we
previously described [41]. Briefly, DENV infected BHK cells in
20 mM Tris, 1 mM EDTA, 1 mM EGTA, 100 mM KCl buffer
(pH 7.4) containing a protease inhibitors cocktail were disrupted
by nitrogen cavitation at 700y for 5 min at 4uC and collected in
an equal volume of buffer containing 1.08 M sucrose. The
homogenates were centrifuged to remove the nucleus and the
supernatant were overlaid with 2 ml each of 0.27 M sucrose
buffer, 0.13 M sucrose buffer, and top buffer (25 mM Tris HCl,
1 mM EDTA, and 1 mM EGTA). The gradient was centrifuged
at 250,000 g 1 h at 4uC. The fractions collected from the top
contained LD, cytosol, microsomal fraction, and pellet. Proteins
from these fractions were precipitated overnight with TCA,
washed with cold acetone, and analyzed by western blot using
anti-C and anti-ADRP (guinea pig anti- ADRP polyclonal
antibodies, Research Diagnostics Inc., Flanders, NJ). The activity
of lactate dehydrogenase (LDH) was measured using the CytoTox
96 kit (Promega) to discard cytosolic contamination in the LD
fraction.
RNA-binding assays
The interaction of the C protein with RNA was analyzed by
filter-binding assays (FBA). Uniformly
32P-labeled RNA probe
corresponding to the viral 59 terminal region (nucleotides 1–160)
was obtained by in vitro transcription using T7 RNA polymerase
and purified on 5% poly-acrylamide gels–6 M urea. The binding
reactions contained 50 mM NaH2PO4 (pH 6), 150 mM NaCl,
0.02% tween 20, 0.1 nM
32P-labeled probe, and increasing
concentrations of C protein (0, 3.75, 7.5, 15, 30, 60, 125, 250,
500, and 1000 nM). For FBA, Nitrocellulose (Protran BA 85,
Whatman-Schleider& Schuell) and Hybond N+ nylon (Amersham
Bioscience) membranes were pre-soaked in binding buffer 50 mM
NaH2PO4 (pH 6), 150 mM NaCl, 0.02% tween 20 and assembled
in a dot-blot apparatus. A 20-mL aliquot of each protein–RNA
mixture was applied to the filters and rinsed with 100 mLo f
binding buffer. Membranes were air-dried and visualized by
PhosphoImaging analysis. The macroscopic binding constants
were estimated by nonlinear regression (Sigma Plot), fitting
Equation 1: Bound %=Boundmax?[Prot]/(Kd+[Prot]), where
Bound % is the percentage of bound RNA, Boundmax is the
maximal percentage of RNA competent for binding, [Prot] is the
concentration of purified C protein, and Kd is the apparent
dissociation constant.
Determination of C protein molecular weight by Static
Light Scattering (SLS)
The average molecular weight (MW) of the proteins was
determined on a Precision Detector PD2010 light-scattering
instrument tandemly connected to an FPLC system and a LKB
2142 differential refractometer. Five hundred ml of C protein
(1 mg/ml) were loaded on a Superdex 75 HR 10/30 (24 ml)
column, size exclusion was performed at 0.4 mL/min with a
running buffer of 200 mM NaH2PO4 (pH 6.0) and 500 mM NaCl.
The 90u light scattering, refractive index, and absorbance of the
eluting material were recorded on a PC computer and analyzed
with the Discovery32 software supplied by Precision Detectors. The
90u light scattering detector was calibrated using BSA as a standard.
Studies with the inhibitor C75
The compound C75, a fatty acid synthase (FAS) inhibitor, was
purchased from Cayman chemicals. For lipid droplet enumeration
in the presence of C75, 5.0610
4 BHK-21 cells were seeded per
well in 24-well plates containing a 1 cm
2 coverslip and allowed to
attach overnight. Cells were mock-infected or DENV-infected
(MOI of 10). The inoculum was removed 1 h post-infection and
0.5 ml of fresh medium supplemented with 2% fetal bovine serum
was added in the presence of 0, 5, 10, or 20 mM of C75. At the
indicated time points post-infection, the slides were fixed and
directly used for lipid droplet enumeration. Cell viability in the
presence of C75 was determined by MTS assay (Cell titer
96HAqueous Non-Radioactive Cell proliferation Assay, Promega).
To evaluate the effect of C75 on DENV replication, the above
protocol was used and the supernatants harvested at 24 and 48 h
post-infection were used for virus quantification by plaque assay.
For studies using the reporter virus carrying luciferase, a viral stock
of mDV-R was first prepared by RNA transfection of BHK cells.
This stock was used to infect cells in the presence of 0, 10, or
20 mM of C75. Luciferase activity was evaluated at 10, 24 and
48 h post-infection. After 48 h of infection, the supernatant was
collected and used to evaluate the release of mDV-R particles by
infecting fresh BHK cells in the absence of C75. Luciferase activity
was then measured 48 h after infection.
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